All News

October 16, 2024

Study seeks to improve brain health in children with Type 1 diabetes

Children with Type 1 diabetes are at increased risk for neurocognitive complications. Vanderbilt University Medical Center has been selected as one of 11 clinical centers in the United States to evaluate children newly diagnosed with Type 1 diabetes for neurocognitive outcomes.

By Jessica Pasley
Graduate student Chiamaka Okoye shows Nora Tidwell, 6, and Avah Floyd, 7, how the gastrointestinal bacterium H. pylori swims through stomach mucus by having them dip their gloved hands into a tub of slime and dried pasta.
October 15, 2024

MEGAMicrobe event for children set for Saturday, Oct. 26

The seventh annual event invites students to conduct science experiments, join in hands-on activities, and win prizes and giveaways.

By Bill Snyder
Cathy Eng, MD
October 15, 2024

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

By Tom Wilemon
David Bichell, MD
October 15, 2024

David Bichell stepping down as chief of Pediatric Cardiac Surgery

Under Bichell’s leadership, the pediatric heart transplant program has consistently had among the highest transplant volumes in the United States, ranking eighth in 2023 for pediatric heart transplant center volumes with 15 transplants performed.

By Christina Echegaray
(iStock image)
October 9, 2024

Grant bolsters nursing workforce retention programs

The new grant will incorporate a two-hour training session that focuses on healthy work environments.

By Matt Batcheldor
Cora Beth Enzor, PharmD, left, and Elizabeth Cherry, PharmD. (photo by Susan Urmy)
October 8, 2024

Vanderbilt Health Rx Solutions introduces service to bridge gap between health systems and pharmaceutical manufacturers

The new consulting service will offer robust capabilities in understanding the provider journey, prescription journey, data capabilities and best practice sharing.

By Holly Fletcher
October 8, 2024

Medical Intensive Care Unit receives American Association of Critical Care Nurses excellence award

This award was created by the AACN to recognize specific units within a hospital system where direct care nurses have the greatest impact on patient outcomes.
By Matt Batcheldor
October 8, 2024

Monroe Carell Jr. Children’s Hospital at Vanderbilt again ranked among nation’s best

Monroe Carell has made the Best Children’s Hospitals list for 18 consecutive years, every year since the ranking’s inception in 2007.
By Christina Echegaray
October 7, 2024

Kimberlyn Ellis selected as 2024 Vanderbilt Prize Student Scholar

Ellis is a computational geneticist with a long-term goal of bridging genomics, bioethics and health policy to promote equitable precision medicine for minority populations.
By Leigh MacMillan
October 7, 2024

Skydiving, bungee jumping, deer hunting and the World Transplant Games: 13 years after getting her new kidney, Sheila Spann keeps living life to the fullest

All that’s in addition to her day jobs as a pharmacist and diabetes educator just outside of Jackson, Mississippi.
By Matt Batcheldor
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.
By Tom Wilemon
October 7, 2024

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.
By Tom Wilemon
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.
By Tom Wilemon